Association of patient mismatch HLA-DP group and HLA-DPB1 TCE mismatching
. | HR . | 95% CI . | P . | N . | |
---|---|---|---|---|---|
Patient mismatch HLA-DP group effect | |||||
PM | DP2 group | 1.00 | 566 | ||
DP5 group | 1.42* | 1.15-1.75 | .001 | 388 | |
Non-PM | DP2 group | 1.00 | 91 | ||
DP5 group | 0.76* | 0.53-1.09 | .138 | 241 | |
HLA-DPB1 TCE mismatching effect | |||||
DP2 group | PM | 1.00 | 566 | ||
Non-PM | 1.67† | 1.20-2.31 | .002 | 91 | |
DP5 group | PM | 1.00 | 388 | ||
Non-PM | 0.94† | 0.74-1.20 | .638 | 241 |
. | HR . | 95% CI . | P . | N . | |
---|---|---|---|---|---|
Patient mismatch HLA-DP group effect | |||||
PM | DP2 group | 1.00 | 566 | ||
DP5 group | 1.42* | 1.15-1.75 | .001 | 388 | |
Non-PM | DP2 group | 1.00 | 91 | ||
DP5 group | 0.76* | 0.53-1.09 | .138 | 241 | |
HLA-DPB1 TCE mismatching effect | |||||
DP2 group | PM | 1.00 | 566 | ||
Non-PM | 1.67† | 1.20-2.31 | .002 | 91 | |
DP5 group | PM | 1.00 | 388 | ||
Non-PM | 0.94† | 0.74-1.20 | .638 | 241 |